Calgary Health Region
13
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
Role: collaborator
A Multicenter Pilot Study of Pallidal Deep Brain Stimulation for Cervical Dystonia
Role: collaborator
Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Role: collaborator
Capsule Endoscopy in Obscure GI Bleeding
Role: collaborator
Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding
Role: collaborator
Sublingual Methadone for the Management of Cancer Breakthrough Pain
Role: collaborator
The Utility of FDG-PET for Radiation Treatment in NSCLC
Role: collaborator
Vaginal Progesterone Versus Placebo in Multiple Pregnancy
Role: collaborator
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
Role: collaborator
Home Vs. Physiotherapy Supervised Rehabilitation After ACL Reconstruction
Role: collaborator
Alberta Hip and Knee Replacement Project
Role: collaborator
Coblation-Tonsillotomy vs Electrocautery-Tonsillectomy for the Treatment of Obstructive Sleep Apnea (OSA) in Children
Role: collaborator
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
Role: collaborator
All 13 trials loaded